col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


30 Ergebisse       Seite 1

 [1] 
Oxford University Press: Antibody Therapeutics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Sep―25 AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains Cristina Moldovan Loomis, Thomas Lahlali, Danielle Van Citters, Megan Sprague, Gregory Neveu, Laurence Somody, et al. (+9)
2 [GO] 2024―Mai―03 A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants Marisa L Yang, Tom Z Yuan, Kara Y Chan, Lin Ding, Zhen Han, Hector Franco, et al. (+14)
3 [GO] 2024―Jan―25 Further Accelerating Biologics Development from DNA to IND: The Journey from COVID-19 to Non-COVID-19 Programs Kee Wee Tan, Pengfei Ji, Hang Zhou, Sam Zhang, Weichang Zhou
4 [GO] 2023―Dez―12 ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks Mohamed A Alfaleh, Reem M Alsulaiman, Sarah A Almahboub, Leena Nezamuldeen, Ayat Zawawi, Najwa D Aljehani, et al. (+13)
5 [GO] 2023―Okt―17 In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2 Dora Buzas, H Adrian Bunzel, Oskar Staufer, Emily J Milodowski, Grace L Edmunds, Joshua C Bufton, et al. (+30)
6 [GO] 2023―Jul―26 CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS Jessica Hong, Hyung Joon Kwon, Raul Cachau, Kevin John Butay, Zhijian Duan, Dan Li, et al. (+6)
7 [GO] 2023―Apr―13 Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including BQ.1.1, CA.3.1, CH.1.1, XBB.1.16, and XBB.1.5 Kevin C Entzminger, Jonathan K Fleming, Paul D Entzminger, Lisa Yuko Espinosa, Alex Samadi, Yuko Hiramoto, et al. (+2)
8 [GO] 2023―Mrz―07 Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protection Huabing Yang, Yuxin Chen, Dongcheng Jiang, Xiaoli Feng, Ying Xu, Jiayu Wei, et al. (+10)
9 [GO] 2023―Feb―17 Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single B-cell cloning method Yang Dou, Ke Xu, Yong-Qiang Deng, Zijing Jia, Jun Lan, Xiaoyu Xu, et al. (+13)
10 [GO] 2023―Jan―20 DESIGN OF a CHIMERIC ACE-2/fc-SILENT FUSION PROTEIN WITH ULTRAHIGH AFFINITY AND NEUTRALIZING CAPACITY FOR SARS-CoV-2 VARIANTS Neil M Bodie, Rina Hashimoto, David Connolly, Jennifer Chu, Kazuo Takayama, Bruce D Uhal
11 [GO] 2022―Dez―29 Comparative assessment of the binding and neutralization activity of bispecific antibodies against SARS-CoV-2 variants Alexis Q Dean, Charles B Stauft, Julianne D Twomey, Joshua Tan, Luca Varani, Tony Wang, Baolin Zhang
12 [GO] 2022―Jul―11 Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein Muhammad S Khan, Eun Kim, Alex McPherson, Florian J Weisel, Shaohua Huang, Thomas W Kenniston, et al. (+5)
13 [GO] 2022―Mai―12 Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 Variants Emily Engelhart, Randolph Lopez, Ryan Emerson, Charles Lin, Colleen Shikany, Daniel Guion, et al. (+2)
14 [GO] 2022―Mrz―17 A rapid bead-based assay for screening of SARS-CoV-2 neutralising antibodies Santhik Subhasingh Lupitha, Pramod Darvin, Aneesh Chandrasekharan, Shankara Narayanan Varadarajan, Soumya Jaya Divakaran, Sreekumar Easwaran, et al. (+6)
15 [GO] 2022―Jan―15 Longitudinal waning of mRNA vaccine-induced neutralizing antibodies against SARS-CoV-2 detected by an LFIA rapid test Qiao Wang, Lili Feng, Haohai Zhang, Juehua Gao, Changchuin Mao, Esther Landesman-Bollag, et al. (+5)
16 [GO] 2021―Aug―28 Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential Tracey E Mullen, Rashed Abdullah, Jacqueline Boucher, Anna Susi Brousseau, Narayan K Dasuri, Noah T Ditto, et al. (+8)
17 [GO] 2021―Aug―28 A novel IgM intranasal intervention against SARS-CoV-2 Antony Yerabham, Mitchell Ho
18 [GO] 2021―Jul―23 SARS-CoV-2 receptor binding mutations and antibody contact sites Marios Mejdani, Kiandokht Haddadi, Chester Pham, Radhakrishnan Mahadevan
19 [GO] 2021―Jun―25 Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection D Bottino, G Hather, L Yuan, M Stoddard, L White, A Chakravarty
20 [GO] 2021―Jun―24 Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers Saleh Riahi, Jae Hyeon Lee, Shuai Wei, Robert Cost, Alessandro Masiero, Catherine Prades, et al. (+5)
21 [GO] 2021―Mrz―20 Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2 Donovan Guttieres, Anthony J Sinskey, Stacy L Springs
22 [GO] 2020―Dez―29 Neutralizing Antibodies against SARS-CoV-2: Current Understanding, Challenge and Perspective Yang Huang, Hui Sun, Hai Yu, Shaowei Li, Qingbing Zheng, Ningshao Xia
23 [GO] 2020―Nov―25 Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic Yaping Sun, Mitchell Ho
24 [GO] 2020―Aug―19 COVID-19 Antibody Therapeutics Tracker: A Global Online Database of Antibody Therapeutics for the Prevention and Treatment of COVID-19 Lifei Yang, Weihan Liu, Xin Yu, Meng Wu, Janice M Reichert, Mitchell Ho
25 [GO] 2020―Aug―16 Innate Immune-mediated Antiviral Response to SARS-CoV-2 and Convalescent sera a potential Prophylactic and Therapeutic Agent to Tackle COVID-19 Abdullah Abdullah, Shah Faisal, Komal Aman, Anees ur Rahman
26 [GO] 2020―Jun―07 Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University Yubin Li
27 [GO] 2020―Mai―27 Convalescent Plasma Transfusion a Promising Therapy for Coronavirus Diseases 2019 (COVID-19): Current updates Henu Kumar Verma, Batoul Farran, Lakkakula V K S Bhaskar
28 [GO] 2020―Mai―20 Perspectives on the development of neutralizing antibodies against SARS-CoV-2 Mitchell Ho
29 [GO] 2020―Apr―30 Antibody therapies for the treatment of COVID-19 Zhiqiang Ku, Xiaohua Ye, Georgina Toa Salazar, Ningyan Zhang, Zhiqiang An
30 [GO] 2020―Apr―30 Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy Xin Zeng, Lingfang Li, Jing Lin, Xinlei Li, Bin Liu, Yang Kong, et al. (+6)
 [1] 

30 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec